Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis
View ORCID ProfileAnn-Marie Mallon, Dieter A. Häring, View ORCID ProfileFrank Dahlke, View ORCID ProfilePiet Aarden, Soroosh Afyouni, Daniel Delbarre, Khaled El Emam, View ORCID ProfileHabib Ganjgahi, View ORCID ProfileStephen Gardiner, View ORCID ProfileChun Hei Kwok, Dominique M. West, View ORCID ProfileEwan Straiton, Sibylle Haemmerle, Adam Huffman, View ORCID ProfileTom Hofmann, View ORCID ProfileLuke J. Kelly, Peter Krusche, Marie-Claude Laramee, Karine Lheritier, Greg Ligozio, Aimee Readie, Luis Santos, View ORCID ProfileThomas E. Nichols, Janice Branson, Chris Holmes
doi: https://doi.org/10.1101/2021.02.16.21251799
Ann-Marie Mallon
1MRC Harwell Institute, Harwell Campus, Oxfordshire, OX11 0RD, UK
Dieter A. Häring
2Novartis Pharma AG, Basel, Switzerland
Frank Dahlke
2Novartis Pharma AG, Basel, Switzerland
Piet Aarden
2Novartis Pharma AG, Basel, Switzerland
Soroosh Afyouni
4Big Data Institute, University of Oxford Li Ka Shing Centre for Health Information and Discovery, Old Road Campus, Oxford, OX3 7LF, UK
Daniel Delbarre
1MRC Harwell Institute, Harwell Campus, Oxfordshire, OX11 0RD, UK
Khaled El Emam
6Children’s Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, Ontario K1J 8 L1, Canada
Habib Ganjgahi
3Department of Statistics, University of Oxford, 24-29 St Giles’, Oxford OX1 3LB, Oxford, UK
Stephen Gardiner
1MRC Harwell Institute, Harwell Campus, Oxfordshire, OX11 0RD, UK
Chun Hei Kwok
1MRC Harwell Institute, Harwell Campus, Oxfordshire, OX11 0RD, UK
Dominique M. West
1MRC Harwell Institute, Harwell Campus, Oxfordshire, OX11 0RD, UK
Ewan Straiton
1MRC Harwell Institute, Harwell Campus, Oxfordshire, OX11 0RD, UK
Sibylle Haemmerle
2Novartis Pharma AG, Basel, Switzerland
Adam Huffman
4Big Data Institute, University of Oxford Li Ka Shing Centre for Health Information and Discovery, Old Road Campus, Oxford, OX3 7LF, UK
Tom Hofmann
2Novartis Pharma AG, Basel, Switzerland
Luke J. Kelly
3Department of Statistics, University of Oxford, 24-29 St Giles’, Oxford OX1 3LB, Oxford, UK
4Big Data Institute, University of Oxford Li Ka Shing Centre for Health Information and Discovery, Old Road Campus, Oxford, OX3 7LF, UK
Peter Krusche
2Novartis Pharma AG, Basel, Switzerland
Marie-Claude Laramee
2Novartis Pharma AG, Basel, Switzerland
Karine Lheritier
2Novartis Pharma AG, Basel, Switzerland
Greg Ligozio
5Novartis Pharma AG, East Hanover, USA
Aimee Readie
5Novartis Pharma AG, East Hanover, USA
Luis Santos
1MRC Harwell Institute, Harwell Campus, Oxfordshire, OX11 0RD, UK
Thomas E. Nichols
4Big Data Institute, University of Oxford Li Ka Shing Centre for Health Information and Discovery, Old Road Campus, Oxford, OX3 7LF, UK
Janice Branson
2Novartis Pharma AG, Basel, Switzerland
Chris Holmes
3Department of Statistics, University of Oxford, 24-29 St Giles’, Oxford OX1 3LB, Oxford, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Not applicable
Posted February 23, 2021.
Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis
Ann-Marie Mallon, Dieter A. Häring, Frank Dahlke, Piet Aarden, Soroosh Afyouni, Daniel Delbarre, Khaled El Emam, Habib Ganjgahi, Stephen Gardiner, Chun Hei Kwok, Dominique M. West, Ewan Straiton, Sibylle Haemmerle, Adam Huffman, Tom Hofmann, Luke J. Kelly, Peter Krusche, Marie-Claude Laramee, Karine Lheritier, Greg Ligozio, Aimee Readie, Luis Santos, Thomas E. Nichols, Janice Branson, Chris Holmes
medRxiv 2021.02.16.21251799; doi: https://doi.org/10.1101/2021.02.16.21251799
Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis
Ann-Marie Mallon, Dieter A. Häring, Frank Dahlke, Piet Aarden, Soroosh Afyouni, Daniel Delbarre, Khaled El Emam, Habib Ganjgahi, Stephen Gardiner, Chun Hei Kwok, Dominique M. West, Ewan Straiton, Sibylle Haemmerle, Adam Huffman, Tom Hofmann, Luke J. Kelly, Peter Krusche, Marie-Claude Laramee, Karine Lheritier, Greg Ligozio, Aimee Readie, Luis Santos, Thomas E. Nichols, Janice Branson, Chris Holmes
medRxiv 2021.02.16.21251799; doi: https://doi.org/10.1101/2021.02.16.21251799
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12175)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3832)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)